Kanabo Group (KNB) Competitors GBX 0.80 -0.10 (-11.11%) (As of 12/20/2024 11:09 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors KNB vs. TLY, SPI, MGP, SBI, OKYO, OPTI, AKR, OBI, STX, and AORShould you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), OKYO Pharma (OKYO), OptiBiotix Health (OPTI), Akers Biosciences (AKR), Ondine Biomedical (OBI), Shield Therapeutics (STX), and AorTech International (AOR). These companies are all part of the "medical" sector. Kanabo Group vs. Totally Spire Healthcare Group Medica Group Sourcebio International OKYO Pharma OptiBiotix Health Akers Biosciences Ondine Biomedical Shield Therapeutics AorTech International Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Do analysts recommend TLY or KNB? Totally presently has a consensus target price of GBX 20, indicating a potential upside of 163.16%. Given Totally's stronger consensus rating and higher probable upside, equities analysts plainly believe Totally is more favorable than Kanabo Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Totally 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kanabo Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of TLY or KNB? 51.3% of Totally shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 13.3% of Totally shares are owned by company insiders. Comparatively, 37.0% of Kanabo Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, TLY or KNB? Totally has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the S&P 500. Does the MarketBeat Community favor TLY or KNB? Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users. CompanyUnderperformOutperformTotallyOutperform Votes13172.78% Underperform Votes4927.22% Kanabo GroupN/AN/A Does the media favor TLY or KNB? In the previous week, Totally had 2 more articles in the media than Kanabo Group. MarketBeat recorded 2 mentions for Totally and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 beat Totally's score of -0.56 indicating that Kanabo Group is being referred to more favorably in the news media. Company Overall Sentiment Totally Negative Kanabo Group Neutral Is TLY or KNB more profitable? Kanabo Group has a net margin of 0.00% compared to Totally's net margin of -2.94%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.Company Net Margins Return on Equity Return on Assets Totally-2.94% -8.85% -2.42% Kanabo Group N/A -83.19%-20.89% Which has stronger valuation & earnings, TLY or KNB? Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTotally£106.68M0.14-£3.13M-£0.02-380.00Kanabo Group£1.14M4.44-£8.18M-£0.01-80.00 SummaryTotally beats Kanabo Group on 10 of the 17 factors compared between the two stocks. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Get Kanabo Group News Delivered to You Automatically Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KNB vs. The Competition Export to ExcelMetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON ExchangeMarket Cap£5.06M£1.45B£5.14B£1.90BDividend YieldN/A3.79%5.09%5.45%P/E Ratio-80.00209.5590.131,863.09Price / Sales4.4454.381,116.25392,686.74Price / Cash1.8213.4543.1028.61Price / Book0.802.314.782.80Net Income-£8.18M£52.03M£120.31M£155.77M7 Day Performance-15.79%-1.00%-1.92%-2.02%1 Month Performance-20.00%1.99%13.65%21.64%1 Year Performance-33.99%12.94%28.34%29.70% Kanabo Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KNBKanabo GroupN/AGBX 0.80-11.1%N/A-38.5%£5.06M£1.14M-80.0020Gap UpTLYTotally2.2501 of 5 starsGBX 8.10flatGBX 20+146.9%+33.3%£15.92M£106.68M-408.601,668News CoverageSPISpire Healthcare Group2.2924 of 5 starsGBX 228-0.2%GBX 322+41.2%-1.5%£920.71M£1.44B3,278.57420MGPMedica GroupN/AGBX 211flatN/A+0.0%£259.85M£76.98M3,516.671,212News CoverageSBISourcebio InternationalN/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap UpHigh Trading VolumeOKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007News CoverageGap DownOPTIOptiBiotix HealthN/AGBX 22.60+6.6%N/A-26.9%£22.13M£1.26M-753.331High Trading VolumeAKRAkers BiosciencesN/AGBX 57.50flatN/A+0.0%£21.64M£2.32M-0.44120OBIOndine BiomedicalN/AGBX 7.75+2.0%N/A-6.2%£21.49M£1.63M-258.33N/AGap DownSTXShield TherapeuticsN/AGBX 2.68-2.9%N/A-57.9%£20.92M£21.47M-68.0040,000AORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383 Related Companies and Tools Related Companies Totally Alternatives Spire Healthcare Group Alternatives Medica Group Alternatives Sourcebio International Alternatives OKYO Pharma Alternatives OptiBiotix Health Alternatives Akers Biosciences Alternatives Ondine Biomedical Alternatives Shield Therapeutics Alternatives AorTech International Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:KNB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kanabo Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kanabo Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
